Diclofenac (DIC) is one of the non-steroidal anti-inflammatory drugs (NSAID) with higher
consumption rates, used in both human and veterinary medicine. Previous studies already …

CO 2-driven acidification and emerging contaminants, such as pharmaceuticals, pose new
threats for the maintenance of natural populations of marine organisms by interfering with …

The presence of pharmaceuticals in the marine environment is a growing problem of global
importance. Although awareness of the significance of this issue is increasing, many …

Little is known about the consequences of exposure to pharmaceuticals and personal care
products (PPCPs) in elevated temperatures associated with climate change. To increase the …

The use of pharmaceutical drugs has systematically increased, resulting in their
environmental presence and exertion of effects on non-target aquatic organisms. Diclofenac …

Seawater acidification could alter the susceptibility of marine organisms to emerging
contaminants, such as pharmaceuticals. In this study, the combined effects of seawater …

The entrance of the anti-inflammatory diclofenac in water bodies is a consequence of
inappropriate use, incorrect disposal, and inefficiency of wastewater treatment plants …

The presence of pharmaceuticals in the aquatic ecosystem has become a topic of growing
interest in recent years. In this study, the marine clam Ruditapes philippinarum was exposed …

Diclofenac (DCF) has been detected in significant amounts in municipal treated wastewater
effluent. Diverse studies report that trace concentrations of DCF may induce toxic effects on …

Ocean acidification and warming are among the man-induced factors that most likely impact
aquatic wildlife worldwide. Besides effects caused by temperature rise and lowered pH …